Form 4: Bank7 CFO Sells Shares Under Pre-Arranged Plan

Bank7 Corp.'s EVP and CFO, Kelly J. Harris, sold a total of 5,000 shares of common stock in early September 2025 under a Rule 10b5-1 trading plan.

Summary

• Kelly J. Harris, Executive Vice President and Chief Financial Officer of Bank7 Corp. (BSVN), reported the sale of common stock.
• On September 2, 2025, 1,688 shares of common stock were sold at a weighted average price of $49.2795 per share.
• On September 3, 2025, an additional 3,312 shares of common stock were sold at a weighted average price of $48.383 per share.
• The total number of shares sold across both transactions is 5,000.
• These transactions were executed pursuant to a Rule 10b5-1(c) trading plan.
• Following these sales, Kelly J. Harris beneficially owns 17,583 shares of common stock.
• Beneficial ownership includes various restricted stock unit grants with future vesting dates, such as 1,191 RSUs vesting in three equal installments on July 29, 2026, 2027, and 2028; 3,237 RSUs vesting in three equal installments on February 15, 2026, 2027, and 2028; 1,125 RSUs vesting on December 17, 2025; 2,692 RSUs vesting in equal installments on February 15, 2026, and 2027; and 1,510 RSUs vesting on February 15, 2026.

Sentiment

Score: 5

Explanation: The sale of shares by a key executive is a routine disclosure for a Form 4. The fact that it was conducted under a Rule 10b5-1 plan suggests it was pre-scheduled for personal financial planning, rather than a reaction to new company developments, thus maintaining a neutral sentiment.

Positives

• The transactions were conducted under a Rule 10b5-1(c) plan, indicating pre-scheduled sales for personal financial planning rather than a reaction to new, non-public company information.

Negatives

• A key executive, the EVP and CFO, sold a significant number of shares (5,000 shares), which can sometimes be perceived as a slight negative by investors, even if pre-arranged.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's financial performance or strategic direction, focusing solely on insider transaction details.

Industry Context

This Form 4 filing is a routine disclosure of an insider stock transaction and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: May observe the executive's share sale, but the pre-arranged nature under a 10b5-1 plan typically mitigates concerns about its signaling effect on company performance.

Next Steps

• Future vesting of 1,191 restricted stock units in equal installments on July 29, 2026, 2027, and 2028.
• Future vesting of 3,237 restricted stock units in equal installments on February 15, 2026, 2027, and 2028.
• Future vesting of 1,125 restricted stock units on December 17, 2025.
• Future vesting of 2,692 restricted stock units in equal installments on February 15, 2026, and 2027.
• Future vesting of 1,510 restricted stock units on February 15, 2026.

Key Dates

Recommendation

The filing reports a pre-scheduled sale of shares by a key executive under a Rule 10b5-1 plan. This type of transaction is generally for personal financial management and does not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and monitor broader company performance and market conditions.

Keywords

Bank7 Corp, BSVN, Form 4, insider trading, stock sale, executive compensation, Kelly J Harris, CFO, restricted stock units, 10b5-1 plan